Aragen Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TRAMADOL HYDROCHLORIDE, with a corresponding US DMF Number 20632.
Remarkably, this DMF maintains an Active status since its submission on June 26, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 11, 2013, and payment made on June 14, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II